Joe Rannazzisi

Retired Drug Enforcement Administration (DEA) Senior Executive Service employee with over 29 years of Federal law enforcement experience as a special agent/investigator who is also a licensed pharmacist and attorney.  Until retirement in October 2015, was responsible for oversight and control of all regulatory compliance inspections/investigations and civil and criminal investigations of approximately 1.6 million DEA controlled substance registrants, supervising an authorized workforce of 225 employees and 81 contractors and controlling an operating budget of approximately $356 million. Principal DEA liaison to Federal, state and local law enforcement and regulatory agencies concerning the diversion and illegal distribution of controlled pharmaceuticals and listed chemicals, the clandestine manufacture of controlled substances and the trafficking and abuse of synthetic drugs.

Demonstrated expertise in conducting and supervising multi-jurisdictional, multi-target criminal, civil, and regulatory investigations with positive results.  Nationally-recognized speaker on controlled substance pharmaceuticals and performance enhancing drugs, pharmaceutical diversion, investigations and security, abuse trends, regulatory compliance, listed chemicals and synthetic drugs. Provided training concerning illicit drugs, pharmaceuticals, pharmaceutical control, security, chemicals, synthetic drugs and clandestine laboratories to hundreds of audiences representing law enforcement, attorneys and judges, professional organizations, pharmaceutical industry executives and employees, community groups, Congress, government officials and international partners (including China, Mexico and Turkey) that represented law enforcement, compliance and regulatory control agency counterparts. 

Provided regulatory oversight and supervised the inspection and investigation of all businesses that import, export, manufacture, distribute or dispense controlled substances and listed chemicals to ensure compliance with regulatory requirements related to drug and facility security, recordkeeping and accountability. DEA regulatory investigations include on-site inspection and review of physical security controls and procedures employed at DEA registered controlled substance manufacturing and distribution sites throughout the United States. Evaluated registrant violations and, when appropriate, issued/approved Orders to Show Cause and Immediate Suspension Orders to initiate administrative procedings for registration suspension/revocation actions. Designated the United States Competant Authority for controlled substances and listed chemicals and supervised U.S. representatives attending meetings organized by the International Narcotics Control Board (INCB) and the Commission on Narcotic Drugs (CND). 

Additional information available upon request.